Literature DB >> 34313887

Cutting Instruments to Cut Costs: A Simple Initiative with Breast Surgical Operating Room Trays that Resulted in Substantial Savings.

Jandie L Schwartz1, Lindsey Kirkpatrick1, Karalyn E Hillebrecht2, Joanna S Lee1, Jennifer G Steiman1, Atilla Soran1, Ronald R Johnson1, Priscilla F McAuliffe1, Emilia J Diego3.   

Abstract

BACKGROUND: A substantial expense in surgical care is incurred in the operating room (OR). We evaluated the financial impact of a systematic reduction in instrument tray contents on charges for breast surgery procedures.
METHODS: A catalog of OR trays historically used for breast procedures (excisional biopsy, segmental and total mastectomy with or without axillary staging) was reviewed by four dedicated breast surgeons and downsized to a single tray accommodating all surgeon preferences. A matched-case comparison was performed pre- and post-downsizing. Cost analysis for salary and benefits (S&B) and unit supply cost (USC) pre- and post-downsizing were carried out. Instrument number, OR tray weights, set-up, and breakdown times were also compared.
RESULTS: Post-downsizing, OR tray counts were reduced from 132 to 67 instruments (49%) and tray weight decreased from 30 to 20 pounds (33%). Scrub technician set-up and breakdown times were shorter by 22% and 25%, respectively. Comparing 449 matched cases (239 pre- and 210 post-downsizing), S&B and USC post-downsizing were decreased collectively for all procedures (p < 0.0001). With an average variance of S&B and USC (pre- to post-intervention) of $354, and an annualized case load of 813 operations, this could translate into S&B and USC savings of $287,802 per year.
CONCLUSION: Simply downsizing OR breast trays resulted in decreased combined S&B and USC per procedure, leading to a substantial cost savings for the healthcare system. This measure aligns with a value and quality-based approach to patient care and could be easily replicated across institutions and specialties.
© 2021. Society of Surgical Oncology.

Entities:  

Year:  2021        PMID: 34313887     DOI: 10.1245/s10434-021-10496-y

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  3 in total

1.  ASO Author Reflections: Locoregional Therapy in De Novo Bone-Only Metastatic Breast Cancer Provides Survival Advantage Regardless of Therapy Sequencing.

Authors:  Atilla Soran; Lutfi Dogan; Serdar Ozbas
Journal:  Ann Surg Oncol       Date:  2021-02-05       Impact factor: 5.344

2.  Current Surgical Management of Inflammatory Breast Cancer.

Authors:  Taiwo Adesoye; Anthony Lucci
Journal:  Ann Surg Oncol       Date:  2021-08-03       Impact factor: 5.344

3.  22nd Annual Virtual Meeting of the American Society of Breast Surgeons: Science, Innovation, and Practice Changes.

Authors:  Katherina Zabicki Calvillo; Sarah L Blair; Henry M Kuerer
Journal:  Ann Surg Oncol       Date:  2021-08-07       Impact factor: 5.344

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.